Yufeng Chen

1.5k total citations
48 papers, 1.1k citations indexed

About

Yufeng Chen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yufeng Chen has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yufeng Chen's work include Colorectal Cancer Surgical Treatments (8 papers), Ferroptosis and cancer prognosis (8 papers) and Colorectal and Anal Carcinomas (5 papers). Yufeng Chen is often cited by papers focused on Colorectal Cancer Surgical Treatments (8 papers), Ferroptosis and cancer prognosis (8 papers) and Colorectal and Anal Carcinomas (5 papers). Yufeng Chen collaborates with scholars based in China, Hong Kong and United States. Yufeng Chen's co-authors include Ping Lan, Xiaojian Wu, Xiaowen He, Xiaosheng He, Yi Li, Gang Li, Xianrui Wu, Qiang Yu, Jiashen Li and Zheng Zhao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Yufeng Chen

47 papers receiving 1.0k citations

Peers

Yufeng Chen

ONCOL

SURGE

BIOMA

Serena Mancarella Italy

Muxing Kang China

Zeng Fan China

Joshua J. Souchek United States

Zubaidah Zakaria Malaysia

Haiping Jiang China

Qijie Dai China

Quan-Xing Ni China

Xiaohong Lü China

Serena Mancarella Italy

Yufeng Chen

507 ×1.2

312 ×0.9

ONCOL

262 ×1.4

149 ×0.9

SURGE

101 ×0.7

BIOMA

Citations per year, relative to Yufeng Chen Yufeng Chen (= 1×) peers Serena Mancarella

Countries citing papers authored by Yufeng Chen

Since Specialization

Citations

This map shows the geographic impact of Yufeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Chen more than expected).

Fields of papers citing papers by Yufeng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Chen. The network helps show where Yufeng Chen may publish in the future.

Co-authorship network of co-authors of Yufeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Chen. A scholar is included among the top collaborators of Yufeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Chen. Yufeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Ting, et al.. (2025). Combined transcriptomics and network pharmacology to elucidate the mechanisms of rutin in treating ischemic stroke rat. Phytomedicine. 148. 157267–157267.

Hu, Chuling, Zhaoliang Yu, Xinxin Huang, et al.. (2024). KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition. Molecular Medicine Reports. 31(1). 2 indexed citations

Chen, Yufeng, Yu Shi, Qiqi Deng, et al.. (2024). MicrobeTCM: A comprehensive platform for the interactions of microbiota and traditional Chinese medicine. Pharmacological Research. 201. 107080–107080. 4 indexed citations

Feng, Yusheng, Zhifen Han, Xuchen Wang, et al.. (2023). Psoralea corylifolia formula extract-loaded silk fibroin/polycaprolactone fibrous membrane for the treatment of colorectal cancer. Colloids and Surfaces B Biointerfaces. 233. 113635–113635. 7 indexed citations

You, Weiqiang, et al.. (2022). Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination. Frontiers in Immunology. 13. 827506–827506. 13 indexed citations

You, Weiqiang, Yufeng Chen, Zerong Cai, et al.. (2022). SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. Frontiers in Immunology. 13. 864244–864244. 36 indexed citations

Lin, Qi, Jia Ke, Zhaoliang Yu, et al.. (2021). Identification of prognostic spatial organization features in colorectal cancer microenvironment using deep learning on histopathology images. CityU Scholars. 2. 100008–100008. 6 indexed citations

Cheng, Bing, Xiaoming Huang, Qian Xiao, et al.. (2021). Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling. Cell Death and Disease. 13(1). 16–16. 63 indexed citations

Chen, Yufeng, Zhaoliang Yu, Zerong Cai, et al.. (2021). Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis. Molecular Medicine. 27(1). 139–139. 22 indexed citations

10.

Ke, Jia, Xiaofeng Jiang, Zhen He, et al.. (2020). Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients. European Journal of Surgical Oncology. 46(10). e62–e70. 8 indexed citations

11.

Zou, Yifeng, Yuming Rong, Jian Xiao, et al.. (2019). A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients. Cancer Cell International. 19(1). 243–243. 19 indexed citations

12.

Wang, Wenyu, Keng Gat Lim, Min Feng, et al.. (2018). KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer. Molecular Cancer Therapeutics. 17(9). 1973–1983. 39 indexed citations

13.

Wu, Xianrui, Chi Zhou, Xiaobin Zheng, et al.. (2018). Conversion is a risk factor for postoperative anastomotic leak in rectal cancer patients - A retrospective cohort study. International Journal of Surgery. 53. 298–303. 11 indexed citations

14.

Liu, Xuanhui, Xianrui Wu, Chi Zhou, et al.. (2017). Preoperative hypoalbuminemia is associated with an increased risk for intra-abdominal septic complications after primary anastomosis for Crohn’s disease. Gastroenterology report. 5(4). 298–304. 21 indexed citations

15.

Zheng, Xiaobin, Xiang Peng, Xiaoyu Xie, et al.. (2017). Enteral nutrition is associated with a decreased risk of surgical intervention in Crohns disease patients with spontaneous intra-abdominal abscess. Revista Española de Enfermedades Digestivas. 109(12). 834–842. 9 indexed citations

16.

Xie, Maobin, Dejun Fan, Yufeng Chen, et al.. (2016). An implantable and controlled drug-release silk fibroin nanofibrous matrix to advance the treatment of solid tumour cancers. Biomaterials. 103. 33–43. 56 indexed citations

17.

Mao, Genxiang, et al.. (2015). DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis. Acta Pharmaceutica Sinica B. 5(3). 188–193. 23 indexed citations

18.

Zou, Yifeng, Zexian Chen, Xiaowen He, et al.. (2015). High expression levels of unc-51-like kinase 1 as a predictor of poor prognosis in colorectal cancer. Oncology Letters. 10(3). 1583–1588. 22 indexed citations

19.

Chen, Yufeng, Xianrui Wu, Xiaosheng He, et al.. (2015). A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer. Annals of Surgical Oncology. 23(3). 826–832. 19 indexed citations

20.

Li, Gang, Yufeng Chen, Jun Hu, et al.. (2013). A 5-fluorouracil-loaded polydioxanone weft-knitted stent for the treatment of colorectal cancer. Biomaterials. 34(37). 9451–9461. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact